Evidence map›Paper›PMID 37219812›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2024

Encapsulation of MSCs in PRP-Derived Fibrin Microbeads.

Özge Lalegül-Ülker, Şükran Şeker, Ayşe Eser Elçin, Yaşar Murat Elçin

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Özge Lalegül-ÜlkerAnkara University Faculty of Science, and Ankara University Stem Cell Institute, Tissue Engineering, Biomaterials and Nanobiotechnology Laboratory, Ankara, Turkey.
Şükran ŞekerAnkara University Faculty of Science, and Ankara University Stem Cell Institute, Tissue Engineering, Biomaterials and Nanobiotechnology Laboratory, Ankara, Turkey.
Ayşe Eser ElçinAnkara University Faculty of Science, and Ankara University Stem Cell Institute, Tissue Engineering, Biomaterials and Nanobiotechnology Laboratory, Ankara, Turkey.
Yaşar Murat ElçinAnkara University Faculty of Science, and Ankara University Stem Cell Institute, Tissue Engineering, Biomaterials and Nanobiotechnology Laboratory, Ankara, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Platelet-rich plasma (PRP) is a highly concentrated platelet-containing blood plasma that incorporates a significant amount of growth factors and cytokines needed to accelerate the tissue repair process. PRP has been used effectively for many years in the treatment of various wounds by direct injection into the target tissue or impregnation with scaffold or graft materials. Since autologous PRP can be obtained by simple centrifugation, it is an attractive and inexpensive product for use in repairing damaged soft tissues. Cell-based regenerative approaches, which draw attention in the treatment of tissue and organ injuries, are based on the principle of delivering stem cells to damaged sites by various means, including encapsulation. Current biopolymers used in cell encapsulation have some advantages with some limitations. By adjusting its physicochemical properties, PRP-derived fibrin can become an efficient matrix material for encapsulating stem cells. This chapter covers the fabrication protocol of PRP-derived fibrin microbeads and their use to encapsulate stem cells as a general bioengineering platform for prospective regenerative medical applications.

Indexed as

Mesenchymal Stem CellsPlatelet-Rich PlasmaFibrinMicrospheresProspective StudiesFibrinBlood-derived materialsCell encapsulationFibrinMesenchymal stem cellsPersonalized medicinePlatelet-rich plasmaRegenerative medicineTissue engineering

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.